Furthermore, we found that E2F1 was expressed at a higher level in AML‐M2 and AML‐M5 patients (Molm13 cells represent the AML‐M5 subtype) than in healthy donors (Figure 6E). Here, E2F1 is linked to acute myeloid leukemia.